A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis
This study has been completed.
Information provided by Apotex Inc.
First Received on September 29, 2009.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: